8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,722) Views
Editor in Chief Professor Garry Walsh
1178-203X
OtherErratum
Rapidis A, Sarlis N, Lefebvre J-L, et al
Therapeutics and Clinical Risk Management 2008, 4:1381-1381
12 February 2009
Case report
A thyrotoxicosis outbreak due to dietary pills in Paris
Vincent Ioos, Vincent Das, Eric Maury, Jean-Luc Baudel, Jérôme Guéchot, et al
Therapeutics and Clinical Risk Management 2008, 4:1375-1379
07 October 2008
Original Research
Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients
Dimitrios Chantzichristos, Andréasson Björn, Johansson Peter
Therapeutics and Clinical Risk Management 2008, 4:1371-1374
23 September 2008
Original Research
Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer
Thérèse H Franco, Ahmed Khan, Vishal Joshi, Beje Thomas
Therapeutics and Clinical Risk Management 2008, 4:1367-1370
06 October 2008
Original Research
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy
Tamana Walia, J Fernando Quevedo, Timothy J Hobday, Gary Croghan, Aminah Jatoi
Therapeutics and Clinical Risk Management 2008, 4:1363-1366
20 November 2008
Original Research
Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer
Kyriaki Pistevou-Gompaki, Apostolos Hatzitolios, Nikos Eleftheriadis, Evaggelos Boultoukas, George Ntaios, et al
Therapeutics and Clinical Risk Management 2008, 4:1359-1362
02 October 2008
Review
Effects of treatment with antimicrobial agents on the human colonic microflora
Fatemeh Rafii, John B Sutherland, Carl E Cerniglia
Therapeutics and Clinical Risk Management 2008, 4:1343-1357
16 December 2008
Review
Newer treatments for fibromyalgia syndrome
Richard E Harris, Daniel J Clauw
Therapeutics and Clinical Risk Management 2008, 4:1331-1342
18 December 2008
Review
Tadalafil in the treatment of erectile dysfunction
Robert M Coward, Culley C Carson
Therapeutics and Clinical Risk Management 2008, 4:1315-1329
14 December 2008
Review
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-Centeno
Therapeutics and Clinical Risk Management 2008, 4:1305-1313
18 December 2008
Review
Exemestane in early breast cancer: a review
Michael Untch, Christian Jackisch
Therapeutics and Clinical Risk Management 2008, 4:1295-1304
10 December 2008
Review
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
PH Chandrasekar
Therapeutics and Clinical Risk Management 2008, 4:1285-1294
07 December 2008
Review
Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients
Leo Flamholc, Magnus Gisslén
Therapeutics and Clinical Risk Management 2008, 4:1281-1284
09 December 2008
Review
Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
Rafael Zaragoza, Javier Pemán, Miguel Salavert, Ángel Viudes, Amparo Solé, et al
Therapeutics and Clinical Risk Management 2008, 4:1261-1280
11 November 2008
Review
Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax®
Moisés Calderón, Tove Brandt
Therapeutics and Clinical Risk Management 2008, 4:1255-1260
16 November 2008
Review
Vinflunine in the treatment of bladder cancer
Mark Bachner, Maria De Santis
Therapeutics and Clinical Risk Management 2008, 4:1243-1253
17 November 2008
Review
Bazedoxifene for the prevention of postmenopausal osteoporosis
Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Giuseppe Martini, Ranuccio Nuti
Therapeutics and Clinical Risk Management 2008, 4:1229-1242
18 September 2008
Review
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Daanish Hoda, George R Simon, Christopher R Garrett
Therapeutics and Clinical Risk Management 2008, 4:1221-1227
01 September 2008
Review
Febuxostat in the management of hyperuricemia and chronic gout: a review
Miao Hu, Brian Tomlinson
Therapeutics and Clinical Risk Management 2008, 4:1209-1220
16 September 2008
Review
Mometasone furoate in the management of asthma: a review
Ricardo A Tan, Jonathan Corren
Therapeutics and Clinical Risk Management 2008, 4:1201-1208
25 September 2008
Review
Impact of PPIs on patient focused symptomatology in GERD
ABR Thomson
Therapeutics and Clinical Risk Management 2008, 4:1185-1200
11 February 2009
Review
Recombinant human growth hormone in the treatment of Turner syndrome
Bessie E Spiliotis
Therapeutics and Clinical Risk Management 2008, 4:1177-1183
09 December 2008
Review
Treatment of severe psoriasis with infliximab
JA Leman, AD Burden
Therapeutics and Clinical Risk Management 2008, 4:1165-1175
27 November 2008
Review
Gemcitabine and taxanes in metastatic breast cancer: a systematic review
Vinay Gudena, Alberto J Montero, Stefan Glück
Therapeutics and Clinical Risk Management 2008, 4:1157-1164
08 October 2008
Review
Tolvaptan and its potential in the treatment of hyponatremia
Megan B Dixon, Y Howard Lien
Therapeutics and Clinical Risk Management 2008, 4:1149-1155
22 October 2008
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
